Global $850.86 Million Nutrigenomics Market Outlook, 2025

3/14/2019, 11:46 AM (Source: GlobeNewswire)

Dublin, March 14, 2019 (GLOBE NEWSWIRE) -- The "Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025" report has been added to's offering.

The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%.

This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.

Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2017 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.

Further key findings from the study suggest:

  • The global nutrigenomics demand exceeded USD 250 million in 2017 and is expected to expand at a CAGR of 16.48% over the forecast period
  • Obesity application segment led the market in 2017 and is estimated to account for a 38% of the industry share by 2025
  • North America accounted for the largest market share in 2017 and is estimated to maintain its dominance over the years to come
  • The Asia Pacific market is projected to witness substantial growth over the next decade owing to increasing cases of obesity and CVD-related deaths
  • Key participants in the global nutrigenomics market include Koninklijke DSM N.V. (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; and Cell Logic

Topics Covered

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Nutrigenomics Market Variables, Trends& Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis Increasing prevalence of obesity Increasing popularity for personalized diet Intense research for cancer prevention and cure
3.1.2 Market Restrain Analysis Lack of regulatory approvals Lack of proven results for nutrigenomics study support
3.2 Penetration & growth prospect mapping
3.3 Nutrigenomics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's

Chapter 4 Nutrigenomics: Application Scope Estimates & Trend Analysis
4.1 Nutrigenomics market: application scope movement analysis
4.2 Obesity
4.3 Cardiovascular Diseases
4.4 Cancer research

Chapter 5 Nutrigenomics: Regional Estimates & Trend Analysis, by Technique, Application, Indication Scope
5.1 Nutrigenomics market share by region, 2016 & 2025
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.2.1 Royal DSM
6.2.2 BASF
6.2.3 Danone
6.2.4 GeneSmart
6.2.5 Unilever
6.2.6 Genova Diagnostics
6.2.7 NutriGenomix, Inc.
6.2.8 Metagenics
6.2.9 Cell Logic
6.2.10 WellGen

For more information about this report visit

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics


Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.